Adjusting for Confounders in Outcome Studies Using the Korea National Health Insurance Claim Database: A Review of Methods and Applications
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objectives: Adjusting for potential confounders is crucial for producing valuable evidence in outcome studies. Although numerous studies have been published using the Korea National Health Insurance Claim Database, no study has critically reviewed the methods used to adjust for confounders. This study aimed to review these studies and suggest methods and applications to adjust for confounders.Methods: We conducted a literature search of electronic databases, including PubMed and Embase, from January 1, 2021 to December 31, 2022. In total, 278 studies were retrieved. Eligibility criteria were published in English and outcome studies. A literature search and article screening were independently performed by 2 authors and finally, 173 of 278 studies were included.Results: Thirty-nine studies used matching at the study design stage, and 171 adjusted for confounders using regression analysis or propensity scores at the analysis stage. Of these, 125 conducted regression analyses based on the study questions. Propensity score matching was the most common method involving propensity scores. A total of 171 studies included age and/or sex as confounders. Comorbidities and healthcare utilization, including medications and procedures, were used as confounders in 146 and 82 studies, respectively.Conclusions: This is the first review to address the methods and applications used to adjust for confounders in recently published studies. Our results indicate that all studies adjusted for confounders with appropriate study designs and statistical methodologies; however, a thorough understanding and careful application of confounding variables are required to avoid erroneous results.
Abstract
Objectives: Adjusting for potential confounders is crucial for producing valuable evidence in outcome studies. Although numerous studies have been published using the Korea National Health Insurance Claim Database, no study has critically reviewed the methods used to adjust for confounders. This study aimed to review these studies and suggest methods and applications to adjust for confounders.Methods: We conducted a literature search of electronic databases, including PubMed and Embase, from January 1, 2021 to December 31, 2022. In total, 278 studies were retrieved. Eligibility criteria were published in English and outcome studies. A literature search and article screening were independently performed by 2 authors and finally, 173 of 278 studies were included.Results: Thirty-nine studies used matching at the study design stage, and 171 adjusted for confounders using regression analysis or propensity scores at the analysis stage. Of these, 125 conducted regression analyses based on the study questions. Propensity score matching was the most common method involving propensity scores. A total of 171 studies included age and/or sex as confounders. Comorbidities and healthcare utilization, including medications and procedures, were used as confounders in 146 and 82 studies, respectively.Conclusions: This is the first review to address the methods and applications used to adjust for confounders in recently published studies. Our results indicate that all studies adjusted for confounders with appropriate study designs and statistical methodologies; however, a thorough understanding and careful application of confounding variables are required to avoid erroneous results.
참고문헌 (32)
- Liu F, "Real-world data : a brief review of the methods, applications, challenges and opportunities", BMC Med Res Methodol, 22(1), pp.287~ (2022)[DOI]
- Jager KJ, "Confounding : what it is and how to deal with it", Kidney Int, 73(3), pp.256~260 (2008)[DOI]
- Kim DS, "Association between statins and the risk of kidney cancer incidence and mortality using the Korean National Health Insurance Claims Database", Cancer Control, 29, pp.10732748221111293~ (2022)[DOI]
- Oh J, "Risk of developing depression from endocrine treatment : a nationwide cohort study of women administered treatment for breast cancer in South Korea", Front Oncol, 12, pp.980197~ (2022)[DOI]
- Park JS, "Clinical study using healthcare claims database", J Rheum Dis, 28(3), pp.119~125 (2021)[DOI]
- Kim H, "The prevalence of concomitant abdominal aortic aneurysm and cancer", J Clin Med, 10(17), pp.3847~ (2021)[DOI]
- Choi H, "Entecavir versus tenofovir for the prevention of hepatocellular carcinoma in treatment-naïve chronic hepatitis B patients in Korea", J Korean Med Sci, 36(14), pp.e89~ (2021)[DOI]
- Yoon HJ, "Risk of cancer following the use of N-nitrosodimethylamine(NDMA)contaminated ranitidine products : a nationwide cohort study in South Korea", J Clin Med, 10(1), pp.153~ (2021)[DOI]
- Lee J, "Pregnancy outcomes after living kidney donation from a nationwide population-based cohort study from Korea", Sci Rep, 12(1), pp.22412~ (2022)[DOI]
- Kim K, "Urbanicity, posttraumatic stress disorder, and effect modification by socioeconomic position : a nested case-control study of the Korean National Health Insurance Database", Acta Psychiatr Scand, 147(1), pp.54~64 (2023)[DOI]
- Sohn SY, "Risk of all-cause mortality in levothyroxine-treated hypothyroid patients : a nationwide Korean cohort study", Front Endocrinol(Lausanne), 12, pp.680647~ (2021)[DOI]
- Kim M, "Herpes zoster and subsequent cancer risk : a nationwide population-based cohort study in Korea", Dermatology, 237(1), pp.73~78 (2021)[DOI]
- Park EH, "Pregnancy outcomes in Korean women with ankylosing spondylitis", Korean J Intern Med, 36(3), pp.721~730 (2021)[DOI]
- Jeong Y, "The risk for future cerebrovascular disease in pregnant women with Moyamoya disease : a nationwide population-based study in South Korea", BMC Pregnancy Childbirth, 22(1), pp.433~ (2022)[DOI]
- Kim DS, "Statin use and incidence and mortality of breast and gynecology cancer : a cohort study using the National Health Insurance claims database", Int J Cancer, 150(7), pp.1156~1165 (2022)[DOI]
- Austin PC, "Applying propensity score methods in clinical research in neurology", Neurology, 97(18), pp.856~863 (2021)[DOI]
- Park S, "The disease burden of migraine patients receiving prophylactic treatments in Korea : a population-based claims database analysis", BMC Health Serv Res, 22(1), pp.902~ (2022)[DOI]
- Han S, "Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation : a nationwide, population-based study in Korea", J Arrhythm, 37(5), pp.1240~1249 (2021)[DOI]
- Chow R, "The association between statin and COVID-19 adverse outcomes : national COVID-19 cohort in South Korea", Ann Palliat Med, 11(4), pp.1297~1307 (2022)[DOI]
- Song Y, "Dyslipidemia risk in thyroid cancer patients : a nationwide population-based cohort study", Front Endocrinol(Lausanne), 13, pp.893461~ (2022)[DOI]
- Yun I, "The risk of osteoporotic fractures after gastrectomy : findings from the Korean national sample cohort database(2002-2019)", Front Oncol, 12, pp.1014817~ (2022)[DOI]
- Kim EH, "Impact of maternal age on singleton pregnancy outcomes in primiparous women in South Korea", J Clin Med, 11(4), pp.969~ (2022)[DOI]
- Ha EK, "Association of clinical and social factors with risk of fracture in children with atopic dermatitis", Pediatr Allergy Immunol, 33(2), pp.e13712~ (2022)[DOI]
- Oh TK, "Weekend admission and mortality among patients with sepsis : a nationwide cohort study in South Korea", Acta Anaesthesiol Scand, 65(5), pp.639~647 (2021)[DOI]
- Biondi-Zoccai G, "Are propensity scores really superior to standard multivariable analysis?", Contemp Clin Trials, 32(5), pp.731~740 (2011)[DOI]
- Amoah J, "Comparing propensity score methods versus traditional regression analysis for the evaluation of observational data : a case study evaluating the treatment of gram-negative bloodstream infections", Clin Infect Dis, 71(9), pp.e497~e505 (2020)[DOI]
- Nguyen TL, "Double-adjustment in propensity score matching analysis : choosing a threshold for considering residual imbalance", BMC Med Res Methodol, 17(1), pp.78~ (2017)[DOI]
- Kim KH, "Comorbidity adjustment in health insurance claim database", Health Policy Manag, 26(1), pp.71~78 (2016)
- Health Insurance Review and Assessment Service (HIRA), "Manual for analysis of health insurance claim data to generate health care evidence", HIRA, 34~45 (2018)
- Kim KH, "A comparative study on comorbidity measurements with lookback period using health insurance database : focused on patients who underwent percutaneous coronary intervention", J Prev Med Public Health, 42(4), pp.267~273 (2009)
- Kim KH, "Comparative study on three algorithms of the ICD-10 Charlson comorbidity index with myocardial infarction patients", J Prev Med Public Health, 43(1), pp.42~49 (2010)
- Kim J, "Feasibility of capturing adverse events from insurance claims data using International Classification of Diseases, tenth revision, codes coupled to present on admission indicators", J Patient Saf, 18(5), pp.404~409 (2022)[DOI]